Cornerstone BioPharma Inc., Critical Therapeutics deal
The companies will merge to form Cornerstone Therapeutics Inc. Cornerstone shareholders will receive 101.5 million Critical
Gathering data...
The companies will merge to form Cornerstone Therapeutics Inc. Cornerstone shareholders will receive 101.5 million Critical